Analgesic Activity of Hexaazaisowurtzitane Derivatives


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,03, 11,05, 9] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals.

Об авторах

S. Krylova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Автор, ответственный за переписку.
Email: krylova5935@gmail.com
Россия, Tomsk

T. Povet’eva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

E. Zueva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

N. Suslov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

E. Amosova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

T. Razina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

K. Lopatina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

O. Rybalkina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

Yu. Nesterova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

O. Afanas’eva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

E. Kiseleva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk

S. Sysolyatin

Institute of Problems of Chemical and Energetic Technologies, Siberian Division of the Russian Academy of Sciences

Email: krylova5935@gmail.com
Россия, Biysk

D. Kulagina

Institute of Problems of Chemical and Energetic Technologies, Siberian Division of the Russian Academy of Sciences

Email: krylova5935@gmail.com
Россия, Biysk

V. Zhdanov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Россия, Tomsk


© Springer Science+Business Media, LLC, part of Springer Nature, 2019

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах